INTRODUCTION
Human papillomavirus (HPV) is a common sexually transmitted infection (STI) that may cause cervical cancer and other malignancies including those of the vulva, anus, vagina, penis, head and neck. [1] [2] [3] Unlike many other cancers, cervical cancer occurs early and strikes at the productive period of a woman's life. The incidence rises in 30-34 years of age and peaks at 55-65 years, with a median age of 38 years (age 21-67 years). Estimates suggest that more than 80% of the sexually active women acquire genital HPV by 50 years of age. 4 Skin-to-skin genital contact is a well-recognized mode of transmission for HPV. 5 Cervical cancer is the fourth leading cancer in women globally, but its major burden is felt in the low-and middle-income countries (LMICs) with very limited resources to introduce and sustain effective populationbased cervical cancer screening programs. In most Asian countries including India, cervical cancer is the second most common cancer in women. 6 Cervical cancer accounts for 528,000 cases in the world (445,000 cases in LMICs); it causes 265,700 estimated deaths annually globally, with 230,200 (86.6%) deaths in the LMICs. 7 Cervical cancer is ranked as the most frequent cancer in women in India. India has a population of approximately 365.71 million women above 15 years of age, who are at risk of developing cervical cancer. The current estimates indicate approximately 132,000 new cases diagnosed and 74,000 deaths annually in India, accounting to nearly 1/3 of the global cervical cancer deaths. 8 The majority of the Indian women diagnosed with cervical cancer have never been screened for the disease and around 70% of these cases present in advance stages due to absence of any organized cervical cancer screening program. It has been estimated that there will be around 205496 new cases and 119097 deaths due to cervical carcinoma by 2020 in India. 9 Despite these; there are no large scale public health surveillance programs in cervical cytological screening and human papillomavirus (HPV) typing in India. Awareness about HPV and cervical cancer, use of vaccines can be very helpful in prevention, control and early diagnosis of cervical cancer. Young students could be educated to create awareness in the society regarding HPV and cervical cancer.
The objective of this study was therefore to determine the knowledge, and attitudes, towards human papilloma virus among university students in Mumbai, India which can be utilized to plan the education and awareness strategies for them.
METHODS

Study design and respondents
This descriptive study was performed in May -June 2017, among pharmacy students from Mumbai University, India. The study protocol was approved by V.
V. research Independent Ethics Committee, Mumbai, India. Two hundred students were contacted by study team member in their classrooms and were given a brief introduction about the research project. Those who desired to participate were explained the purpose and objectives of the study. On the basis of the eligibility criterion (those who gave a written informed consent and are registered students of Mumbai University) 142 students were selected for the present study.
Study instrument
The survey questionnaire was prepared in English after reviewing the literature for similar studies. The questionnaire was framed to gather information on demographics and knowledge and attitude toward human papilloma virus infection. A pilot study was done with a sample of 30 students, to know the average time required for face to face interview for completing the questionnaire and to ensure that it is appropriate and understandable to students. Pilot population was not part of the final study.
Collection of data
Students were face to face interviewed in the student office with prior appointment by a study member from a team of 5 trained Bachelor of Pharmacy Students. The purpose of the research was explained to the respondents; anonymity and confidentiality were guaranteed and maintained. The researchers complied with the international ethical guidelines for research. The data was recorded into the predesigned data report form (DRF) by interviewers.
Data entry and analysis
Collected data from individual DRF was entered into Microsoft excel and was verified by the authors other than interviewers. Data was analyzed by using descriptive statistical methods and a bivariate analysis was conducted with all relevant independent variables and Odds Ratios (OR) and their respective 95% Confidence Intervals (CI) were calculated. P-value ≤ 0.05 was considered as significant. IBM SPSS version 23 was used for statistical analysis. The association of gender with their education was not significant (P=0.153). Out of 142 participants only 97 (68%) were aware about HPV which was used for further questions and response analysis.
RESULTS
As shown in Table 2 , respondents had fair knowledge (61% average) about HPV. Out of 8 questions related to knowledge about HPV only for one question i.e. "Is HPV sexually transmitted?" most of the participants (93/97; 96%) gave the correct response 'yes". For questions related to occurrence, incidence and possibility of HPV occurring without symptoms more than 50% respondents gave incorrect responses. For questions related to cause, gender, genital warts and other cancers more than 60% respondents gave correct responses. There were no gender differences related to knowledge about HPV. As seen from the Table 3 , participants had very poor knowledge (18% average) about symptoms, prevention and spread of HPV.
Ninety three percent participants were not able to correctly identify the health problems associated with HPV. Only 16% and 32% of the participants could correctly select right choices for prevention of HPV and spread of HPV respectively.
As shown in Table 4 participants had fair knowledge (50%) about HPV vaccine.
Out of 5 questions related to HPV vaccine, for 2 questions related to vaccination and screening for cervical cancer and HPV vaccination before commencing sexual intercourse 67% participants gave incorrect answers.
Seventy three percent, 62% and 50% participants correctly answered that there is a vaccine to protect against HPV, it prevents the chances of cervical cancers and it is not only for people who are sexually active respectively. As seen in Table 5 , participants had overall good attitude about getting vaccinated against HPV.
DISCUSSION
Cervical cancer is the fourth leading cancer in women globally, but its major burden is felt in the low-and middle-income countries (LMICs) with very limited resources to introduce and sustain effective populationbased cervical cancer screening programs. The knowledge that persistent infection with one of the oncogenic, high-risk types of human papillomaviruses (HPVs) is the 'necessary' cause of cervical cancer, implying that the infection is obligatory to initiate the carcinogenic process, has opened up an exciting and effective means of primary prevention using vaccination. 10, 11 These developments linking HPV to cervical cancer are not known in the community and there is no existing concerted effort to develop public health campaigns to increase this awareness. Community awareness and buyin is critical to the introduction of newer strategies for cervical cancer prevention. 12 Present study indicated overall fair awareness about HPV, and HPV vaccination. Overall awareness (61%) seen in this study was lesser than the study done in Karnataka which reported awareness of 75%. Study done by Pandey et al showed that 89% participants knew the etiology of HPV as compared to 73% from the present study. Both studies showed similar percentage of participants being aware about availability of HPV vaccine. 13 The differences seen in both studies could have originated because Karnataka study was done among medial students as against pharmacy students in the present study. HPV awareness in the present study (61%) was much better as compared to a study done among general population (12%) in Odisha, India. 12 Awareness in present study was better than the study done among university students from Lahore, Pakistan which had 57% awareness of HPV. Only 32% participants had correct
